In cases with raised sperm DNA fragmentation, can sperm selection by magnetic-activated cell sorting or testicular sperm aspiration help improve reproductive outcomes?
Journal of Assisted Reproduction and Genetics · 2024
DOI: 10.1007/s10815-024-03128-3 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Assisted Reproduction and Genetics, 2024. Verfasst von Krishna Chaitanya Mantravadi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Embryology, Oasis Fertility, Banjara Hills Road No. 2, Hyderabad, 500034, Telangana, India. krishna@oasisindia.in. Hauptthemen laut MEDLINE: DNA Fragmentation, Spermatozoa, Sperm Retrieval, Pregnancy Rate. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE: To evaluate the efficacy of magnetic-activated cell sorting (MACS) or testicular sperm aspiration (TESA) to improve reproductive outcomes in cases with elevated sperm DNA fragmentation undergoing assisted reproduction. METHODS: This randomized controlled trial included couples with failed IVF cycles and sperm DNA fragmentation > 30%. Sperm DNA fragmentation was assessed using the sperm chromatin structure assay (SCSA) method. Participants were randomly assigned to either the MACS or TESA group. Testicular sperm retrieval was performed for the TESA group, while MACS involved sperm selection using magnetic beads. Extended blastocyst culture, freeze all policy of blastocysts by vitrification, and frozen embryo transfer were undertaken as per clinic's standard operating protocols. Blastocyst formation rate, implantation rate, miscarriage rate, multiple pregnancy rate, and live birth rate were analyzed and compared between MACS and TESA groups. RESULTS: There were no significant differences in female age, male age, or sperm DNA fragmentation index (DFI) between the MACS and TESA groups. The blastocyst conversion rate was slightly higher in the TESA group (39%) compared to the MACS group (32%). However, the MACS group had a higher implantation rate (50%) than the TESA group (35%). Miscarriage rates, multiple pregnancy rates, and live birth rates did not show statistically significant differences between the groups. A chi-squared test was conducted to compare categorical variables, and t-tests were done to compare continuous variables. CONCLUSION: In cases with raised sperm DNA fragmentation, sperm selection by MACS or TESA seems to offer comparable reproductive outcomes. There seems no superiority of one intervention over the other in cases with raised sperm DNA fragmentation undergoing assisted reproduction. Both interventions seem to be beneficial for couples seeking assisted reproduction with raised sperm DNA fragmentation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Embryology, Oasis Fertility, Banjara Hills Road No. 2, Hyderabad, 500034, Telangana, India. krishna@oasisindia.in.
- Department of Reproductive Endocrinology, Oasis Fertility, Banjara Hills Road No. 2, Hyderabad, 500034, Telangana, India.
Zitieren
APA
Mantravadi, K. C., & Rao, D. (2024). In cases with raised sperm DNA fragmentation, can sperm selection by magnetic-activated cell sorting or testicular sperm aspiration help improve reproductive outcomes?. Journal of Assisted Reproduction and Genetics. https://doi.org/10.1007/s10815-024-03128-3
Vancouver
Mantravadi KC, Rao D. In cases with raised sperm DNA fragmentation, can sperm selection by magnetic-activated cell sorting or testicular sperm aspiration help improve reproductive outcomes?. Journal of Assisted Reproduction and Genetics. 2024. doi:10.1007/s10815-024-03128-3
BibTeX
@article{Mantravadi2024,
author = {Mantravadi, Krishna Chaitanya and Rao, Durga},
title = {In cases with raised sperm DNA fragmentation, can sperm selection by magnetic-activated cell sorting or testicular sperm aspiration help improve reproductive outcomes?},
journal = {Journal of Assisted Reproduction and Genetics},
year = {2024},
doi = {10.1007/s10815-024-03128-3}
}
EUVIMED